Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share

16 hours ago Business NY Post - Business 3

Novo's shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has failed to impress investors.

Read The Rest at : NY Post - Business

Top News

How JPMorgan, Bank of America are cashing in on China Inc. — despite pressure from US lawmakers
The banks are planning to remain on the underwriting team, setting up a nasty confrontation with the committee as CATL begins to sell stock to the...
NJ Gov. Murphy blasts striking NJ Transit union workers leaving 350,000 commuters in travel nightmare
New Jersey Gov. Phil Murphy ripped NJ Transit engineers for going on strike Friday — blasting their actions as a "slap in the face" to commuters...
Dave Portnoy just gave this buzzy new NYC pizza spot a 9.2 rating, and now it’s selling out like crazy — here’s what real New Yorkers think
Locals are waiting hours to get a taste of what’s quickly becoming Manhattan’s most talked-about slice.
Yanks' Cabrera post-surgery: Return starts today
Yankees third baseman Oswaldo Cabrera announced he underwent successful ankle surgery and is looking forward to his return.
After Putin is a no-show at talks in Turkey, Trump says he'll meet the Russian leader soon
President Trump said Friday he's moving to set up direct talks with Russian President Vladimir Putin as soon as he can, after Putin opted to skip...
NJ air traffic controller reveals why he went on ‘trauma leave’: ‘Don’t want to be responsible for killing 400 people’
“I don’t want to be responsible for killing 400 people,” Jonathan Stewart said in a lengthy interview -- as he detailed the frightening ordeal that...